Strides Pharma Science receives 5 USFDA observations after Bengaluru facility inspection
Published on: May 20, 2026, 10:49 p.m. | Source: CNBC TV18
Strides Pharma Science said the USFDA completed a routine cGMP inspection at its flagship Bengaluru facility from May 12 to May 20, 2026, and issued a Form 483 with five observations.
